Statistics

Total Visits

Views
JEVTCC: Phase II trial of cabazitaxel (Cbz) in patients (pt) with advanced or metastatic transitional-cell carcinoma (mTCC), who progressed before 12 months after cisplatin-based chemotherapy-A Spanish Oncologic Genitourinary Group (SOGUG) study39

Select a period of time:

Number of views in the range

Views
JEVTCC: Phase II trial of cabazitaxel (Cbz) in patients (pt) with advanced or metastatic transitional-cell carcinoma (mTCC), who progressed before 12 months after cisplatin-based chemotherapy-A Spanish Oncologic Genitourinary Group (SOGUG) study22

Views

Views
March 20254
April 20252
May 20250
June 20252
July 202513
August 20250
September 20251
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States7
Brazil5
Singapore4
Barbados1
Spain1
United Kingdom1
Paraguay1
Turkey1
South Africa1
 

Top cities views

Views
Adana1
Asunción1
Avondale1
Buda1
Cape Town1
Council Bluffs1
Cuité1
Dallas1
Jundiaí1
Llandrindod Wells1